CuebasDA,PhillipsC,SchmitzW,ConzelmannE,NovikovDK, 2002.The role of alpha-methylacyl-CoA racemase in bile acid synthesis,Biochem J 363 801 -7
FogelBL,PerlmanS., 2006.An approach to the patient with late-onset cerebellar ataxia. Nature clinical practice,Nat Clin Pract Neurol 2 629 -35
BespalovaIN,DurnerM,RitterBP,AngeloGW,Rossy-FullanaE,Carrion-BaraltJ, 2010.Non-synonymous variants in the AMACR gene are associated with schizophrenia,Schizophr Res 124 208 -15
SavolainenK,KottiTJ,SchmitzW,SavolainenTI,SormunenRT,IlvesM, 2004.A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids,Hum Mol Genet 13 955 -65
FerdinandusseS,DenisS,ClaytonPT,GrahamA,ReesJE,AllenJT, 2000.Mutations in the gene encoding peroxisomal [alpha]- methylacyl-CoA racemase cause adult-onset sensory motor neuropathy,Nat Genet 24 188 -91
OuyangB,LeungYK,WangV,ChungE,LevinL,BrackenB, 2011.- Methylacyl-CoA Racemase Spliced Variants and Their Expression in Normal and Malignant Prostate Tissues, 77 1 -7
Van VeldhovenPP,CroesK,CasteelsM,MannaertsGP, 1997.- Methylacyl racemase: a coupled assay based on the use of pristanoyl-CoA oxidase/peroxidase and reinvestigation of its subcellular distribution in rat and human liver,Biochim Biophys Acta 1347 62 -8
StojkovicT., 2016.Hereditary neuropathies: An update,Revue neurologique 172 775 -8
HardingAE,ThomasPK., 1980.The clinical features of hereditary motor and sensory neuropathy types I and II, 103 259 -80
TimmermanV,StricklandAV,ZüchnerS, 2014.Genetics of CharcotMarie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success,Genes (Basel) 5 13 -32
GessB,SchirmacherA,YoungP, 2013.Genetics of neuropathies,Der Nervenarzt 84 157 -65
Lacour A, 2013.Current issues in hereditary neuropathies,Revue neurologique 169 1001 -3
NidhiShukla,JaysreeRath,- Coenzyme A, 2017.Racemase (AMACR) in Colorectal Neoplasia,J Clin Diagn Res 11 EC35 -8
VallatJM,MathisS,FunalotB., 2013.The various Charcot-Marie-Tooth diseases,Curr Opin Neurol 26 473 -80
Dubourg O., 2012.Developments in hereditary neuropathies,Revue neurologique 168 983 -5
ChongCM,AiN,LeeSM, 2017.ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders,Curr Drug Targets 18 455 -62
WuBQ,BiZG,QiQ., 2013.Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats,Chin Med J (Engl) 126 3723 -7